MONDAY, July 17, 2023 (HealthDay Now) — Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States…
You may also like
FDA Approves Dupixent for Chronic Spontaneous Urticaria
Some OB/GYNS Stay in States With Abortion Bans...
Teen Cannabis Use Rises in Canada After Edibles Are...
Federal Prosecutor Questions Medical Journals Over...
Psilocybin Use Dramatically Increasing In U.S.
Muscle Quality Could Be Key To Successful Hip...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.